Shenglan Liu
-
- Phytochemistry and Bioactivity Studies 2
-
- Epigenetics and DNA Methylation 3
-
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 3
-
- Ocular Oncology and Treatments 5
-
- Synthesis and Characterization of Heterocyclic Compounds 3
- Synthesis and biological activity 2
-
- Diabetes Management and Education 2
In The Last Decade
Shenglan Liu
34 papers receiving 628 citations
Peers
Comparison fields: 5 of 104
- Cancer Research 69
- Pharmacology 38
- Sensory Systems 21
- Molecular Biology 288
- Oncology 101
Countries citing papers authored by Shenglan Liu
This map shows the geographic impact of Shenglan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Liu more than expected).
Fields of papers citing papers by Shenglan Liu
This network shows the impact of papers produced by Shenglan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Liu. The network helps show where Shenglan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shenglan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 17 | |
| 7 | 2024 | 13 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 32 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 17 | |
| 12 | 2021 | 36 | |
| 13 | 2020 | 9 | |
| 14 | 2019 | 49 | |
| 15 | 2018 | 7 | |
| 16 | 2018 | 9 | |
| 17 | 2017 | 4 | |
| 18 | 2016 | 35 | |
| 19 | 2015 | 47 | |
| 20 | 2014 | 43 |
About Shenglan Liu
Shenglan Liu is a scholar working on Pharmacology, Ophthalmology and Complementary and alternative medicine, having authored 39 papers that have together received 628 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (5 papers), Cancer Cells and Metastasis (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Cancer-related Molecular Pathways (3 papers), Epigenetics and DNA Methylation (3 papers), Synthesis and biological activity (2 papers), Phytochemistry and Bioactivity Studies (2 papers) and Diabetes Management and Education (2 papers). The work is most often cited by research in Cancer Research (69 citations), Pharmacology (38 citations) and Sensory Systems (21 citations). Shenglan Liu has collaborated with scholars based in China, Australia and Belgium. Frequent co-authors include Jingxuan Pan, Peiqing Liu, Wei Dai, Jianmin Jiang, Shaorui Chen, Boyu Zhang, Jingfeng Zhou, Shuya Sun, Yun Wang and Jun Jin. Their work appears in journals such as The Journal of Organic Chemistry, Cellular and Molecular Life Sciences and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.